Skip to content
Open in App
Baxter International logo

Baxter International

web2

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare product...

Symbol · BAX
Company profile

About

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

People

Company team

MR

Michael R. McDonnell

Independent Director

Company leadership profile.

AA

Amy A. McBride-Wendell

Independent Director

Company leadership profile.

DB

David Brent Shafer

Independent Chairman of the Board

Company leadership profile.

AP

Andrew P. Hider

CEO, President, Interim Group President of Medical Products & Therapies and Director

Company leadership profile.

PB

Patricia B. Morrison

Independent Director

Company leadership profile.

NM

Nancy M. Schlichting

Independent Director

Company leadership profile.

WA

William A. Ampofo

Independent Director

Company leadership profile.

JA

Jeffrey A. Craig

Independent Director

Company leadership profile.

DS

David S. Wilkes

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated Baxter International.

Orbitrum research

Experts evaluating Baxter International

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment